13.60
+0.23(+1.72%)
Currency In USD
| Previous Close | 13.37 |
| Open | 13.25 |
| Day High | 13.63 |
| Day Low | 12.72 |
| 52-Week High | 17.19 |
| 52-Week Low | 10.65 |
| Volume | 58,380.51 |
| Average Volume | 112,072 |
| Market Cap | 361.66M |
| PE | -13.74 |
| EPS | -0.99 |
| Moving Average 50 Days | 12.71 |
| Moving Average 200 Days | 13.25 |
| Change | 0.23 |
If you invested $1000 in CARLSMED, INC. (CARL) since IPO date, it would be worth $937.93 as of March 03, 2026 at a share price of $13.6. Whereas If you bought $1000 worth of CARLSMED, INC. (CARL) shares 0 years ago, it would be worth $937.93 as of March 03, 2026 at a share price of $13.6.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference
GlobeNewswire Inc.
Feb 23, 2026 9:01 PM GMT
CARLSBAD, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at the 2026 Canaccord Genuity Musculoskeletal Conference on
Carlsmed Announces first corra™ personalized Cervical Plating Procedure
GlobeNewswire Inc.
Feb 18, 2026 9:05 PM GMT
The corra™ Cervical Plating System marks the debut of Carlsmed's patient-specific fixation portfolioCARLSBAD, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the first personali
Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
GlobeNewswire Inc.
Feb 11, 2026 9:01 PM GMT
CARLSBAD, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its fourth quarter and full year 2025 financi